Delivery Order SPE2DB20D3505-SPE2DB25FU3J7

Award Date 4/4/25
Potential Completion Date 4/7/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product. The contract has a firm fixed price of $2,197.83 and a period of performance through August 14, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a wide range of...
This is a $10,177.04 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RAMELTEON 8 MG TABLET UD 50S, a medication used to treat insomnia, with a performance period ending on February 26, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RAMELTEON 8 MG TABLET 30S. The contract has a ceiling value of $1,543.74 and will run through August 20, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,508.63 firm fixed-price delivery order is for the supply of RAMELTEON 8 MG TABLET 30S, a medication used to treat insomnia. The award is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $2,681.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RAMELTEON 8 MG TABLET 30S, a prescription medication, with a period of performance through March 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,177,965 units of the sleep medication Ramelteon 8 mg Tablet 30s. The $1,415.04 contract has a performance period through May 8, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,543.17 firm fixed price delivery order is for the supply of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product. The contract has an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,801.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,062,698 units of the prescription medication ramelteon 8 mg tablet, with an ultimate completion date of April 29, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This delivery order was awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of RAMELTEON 8 MG TABLET 30S, a pharmaceutical product. The order is valued at $1,153.53 and has a completion date of September 24, 2024. It is a firm fixed-price contract without a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, leveraging its extensive supply...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,212.24 firm fixed-price delivery order is for the supply of Ramelteon 8 MG Tablet UD 50S, a medication used to treat insomnia. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FU3J7
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,077.38, is for the supply of RAMELTEON 8 MG TABLET 30S, a medication used to treat insomnia. The contract has an ultimate completion date of April 7, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/4/25, 11:27 AM